Showing results (271-280 of 809) with videos related to
Sort By:
Pageof 81
JAMA|August 14, 2003
Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trialPhilippe O Szapary, Megan L Wolfe, LeAnne T Bloedon, et al.The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetesMuredach P Reilly, Nayyar Iqbal, Mark Schutta, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 12, 2013
Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic miceEva Hurt-Camejo, Thomas Gautier, Birgitta Rosengren, et al.Journal of Lipid Research|March 3, 2012
ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasmaWijtske Annema, Arne Dikkers, Jan Freark de Boer, et al.Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.The American Journal of Cardiology|January 8, 2017
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective CohortConnor A Emdin, Amit V Khera, Pradeep Natarajan, et al.Cell Metabolism|August 2, 2005
Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalphaMichael Lehrke, Corinna Lebherz, Segan C Millington, et al.Clinical and Translational Science|February 20, 2010
Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterolFrançois Briand, Snehal U Naik, Ilia Fuki, et al.Circulation Research|January 17, 2015
Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosisKevin M Patel, Alanna Strong, Junichiro Tohyama, et al.Coronary Artery Disease|March 17, 2004
Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemiaDonald B Hunninghake, Evan A Stein, Harold E Bays, et al.Pageof 81